Cornea clinical features and news. - Ophthalmology Times

ADVERTISEMENT

Cornea
Top Story
Eye and cornea research made easier by two antibodies
A global biotechnology company focused in inflammation and neurology research, announced the launch of two monoclonal antibodies (Lumican and Keratocan, MD Biosciences).
Feature Articles
Study: Sodium hyaluronate solution safe, effective
Drop found to be effective quickly in treating signs, symptoms of dry eye disease
Ophthalmology Times
An investigational compound for the treatment of dry eye disease consisting of a proprietary formulation of sodium hyaluronate ophthalmic solution 0.18% (Vismed, Lantibio Inc.) was shown to be safe and effective in a multicenter phase III trial conducted in the United States. A new drug application has been filed for the solution, which is already marketed in parts of Europe and Asia as a viscoelastic lubricant eye drop.
Low IOP is measured with great accuracy using non-contact applanation tonometer
Assessment uses corneal properties to determine pressure, may provide new gold standard
Ophthalmology Times
A non-contact applanation tonometer (Ocular Response Analyzer, Reichert) appears to be more effective than the Goldmann applanation tonometer (GAT) in assessing very low and negative IOP values using the non-contact applanation tonometer's corneal-compensated IOP (IOPcc) parameter. The GAT may be the long-accepted gold standard, but the more accurate assessment of IOP using the non-contact applanation tonometer challenges this gold standard and raises questions as to which of the two techniques is optimal in measuring IOP.
Artificial tear product improves functional visual performance on intensive tasks
Ophthalmology Times
An evaluation of functional visual performance of two currently marketed artificial tear products using the interblink interval visual acuity decay method showed that a tear with a polyethylene glycol/propylene glycol (PEG/PG)-based formulation (Systane Ultra, Alcon Laboratories) resulted in a statistically significant increase in the length of time within one line of best-corrected visual acuity (BCVA) within an interblink period at 90 minutes after instillation of a single drop. The drop was compared with a carboxymethylcellulose/glycerin-based tear (Optive, Allergan). Median times to one-line loss of BCVA were not statistically different at the timepoints of 15 or 45 minutes post-instillation.
When using punctal plugs for dry eye, surgeon favors traditional silicone devices
Occluders made of polyglycolic acid or hydrogel also look promising against dry eye, she says
Ophthalmology Times
When faced with a decision about which type of punctal plug to use in the management of dry eye, one oculofacial plastic surgeon said she turns to traditional occluders made of silicone because they have a long track record and are easily visualized for removal, if necessary. She has not used intracanalicular plugs made of polyglycolic acid or hydrogel but said they seem promising.
Post-LASIK healing rate may be increased by hypromellose gel
Hypromellose found to aid re-epithelialization of gutter around flaps, may improve patient comfort
Ophthalmology Times
Hypromellose 0.3% gel (GenTeal Gel, Novartis Ophthalmics) may increase the rate of re-epithelialization of the gutter around LASIK flaps during the first postoperative week.
News
Eye and cornea research made easier by two antibodies
Ophthalmology Times
A global biotechnology company focused in inflammation and neurology research, announced the launch of two monoclonal antibodies (Lumican and Keratocan, MD Biosciences).
FDA approves Sirion's NDA for ganciclovir 0.15% for herpetic keratitis
Ophthalmology Times E-News
The FDA has approved a new drug application (NDA) for ganciclovir ophthalmic gel 0.15% (Zirgan, Sirion Therapeutics) as a treatment for acute herpetic keratitis (dendritic ulcers), the company announced.
DSEK shown to be safe, effective therapy, according to AAO cornea panel
Ophthalmology Times
Descemet's stripping endothelial Keratoplasty (DSEK) was shown to be a safe and effective treatment for corneal endothelial diseases, according to a 2009 review by the cornea panel of the American Academy of Ophthalmology's (AAO) Ophthalmic Technology Assessment Committee, led by W. Barry Lee, MD.
Dr. Alfonso named chairman at Bascom Palmer
Ophthalmology Times E-News
Eduardo C. Alfonso, MD, has been named chairman of the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, according to a prepared statement.
Bascom Palmer names Eduardo C. Alfonso, MD, its new chairman
Ophthalmology Times
Eduardo C. Alfonso, MD, is the new chairman of the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Alfonso is the fifth chairman to be named in the institute's 47-year history.

ADVERTISEMENT

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here

ADVERTISEMENT



Click here